Abstract
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Yasuko Kobayashi, Takashi Matsuki, Yoji Hamada, Eitaro Nakashima, Hideki Kamiya, Masaki Hata, Toru Nishikawa, Masahide Takahashi, Yutaka Oiso, Jiro Nakamura
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Effects of insulin resistance on endothelial progenitor cells and vascular repair
10.1042/cs20080263 · 2009
Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia
10.1161/01.cir.0000046450.89986.50 · 2003
Therapeutic vasculogenesis using human cord blood-derived endothelial progenitors
10.1016/s1050-1738(01)00128-1 · 2001
Intramuscular transplantation of G-CSF-mobilized CD34(+) cells in patients with critical limb ischemia: a phase I/IIa, multicenter, single-blinded, dose-escalation clinical trial
10.1002/stem.207 · 2009
Endothelial progenitor cells and cardiovascular cell-based therapies
10.1080/14653240802714827 · 2009
Circulating endothelial progenitor cells, vascular function, and cardiovascular risk
10.1056/nejmoa022287 · 2003
Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease
10.1161/hh1301.093953 · 2001
Circulating progenitor cells are reduced in patients with severe lung disease
10.1634/stemcells.2005-0440 · 2006
Endothelial progenitor cells are decreased in blood of cardiac allograft patients with vasculopathy and endothelial cells of noncardiac origin are enriched in transplant atherosclerosis
10.1161/01.cir.0000081703.34526.5d · 2003
Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes
10.2337/diabetes.53.1.195 · 2004
Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures
10.1161/01.cir.0000039526.42991.93 · 2002
Risk factors for coronary artery disease, circulating endothelial progenitor cells, and the role of HMG-CoA reductase inhibitors
10.1111/j.1523-1755.2005.00261.x · 2005
Impaired function of circulating CD34(+) CD45(−) cells in patients with proliferative diabetic retinopathy
10.1016/j.exer.2010.05.012 · 2010
Vascular endothelial growth factor (VEGF) and its receptors
10.1096/fasebj.13.1.9 · 1999
Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization
10.1161/01.res.85.3.221 · 1999
Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration
10.1161/hc0602.103673 · 2002
Akt1/protein kinase Balpha is critical for ischemic and VEGF-mediated angiogenesis
10.1172/jci24726 · 2005
Therapeutic neovascularization using cord blood-derived endothelial progenitor cells for diabetic neuropathy
10.2337/diabetes.54.6.1823 · 2005
Smoking cessation rapidly increases circulating progenitor cells in peripheral blood in chronic smokers
10.1161/01.atv.0000135655.52088.c5 · 2004
Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial
10.1016/s0140-6736(02)09670-8 · 2002
Safety and efficacy of autologous progenitor cell transplantation for therapeutic angiogenesis in patients with critical limb ischemia
10.1253/circj.71.196 · 2007
Circulating endothelial progenitor cells and cardiovascular outcomes
10.1056/nejmoa043814 · 2005
Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease
10.1161/01.cir.0000124476.32871.e3 · 2004
Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity
10.1038/nm1095-1024 · 1995
Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation
10.1074/jbc.273.46.30336 · 1998
Activation of vascular protein kinase C-beta inhibits Akt-dependent endothelial nitric oxide synthase function in obesity-associated insulin resistance
10.2337/diabetes.55.03.06.db05-0771 · 2006
p38 MAPK mediates gamma-irradiation-induced endothelial cell apoptosis, and vascular endothelial growth factor protects endothelial cells through the phosphoinositide 3-kinase-Akt-Bcl-2 pathway
10.1074/jbc.m405777200 · 2004
Vascular endothelial growth factor inhibition by dRK6 causes endothelial apoptosis, fibrosis, and inflammation in the heart via the Akt/eNOS axis in db/db mice
10.2337/db09-0136 · 2009
Synergistic effect of combined intramyocardial CD34+ cells and VEGF2 gene therapy after MI
10.1038/ncpcardio0430 · 2006
Effects of diabetes mellitus on VEGF-induced proliferation response in bone marrow derived endothelial progenitor cells
10.1111/j.1540-8191.2010.01086.x · 2010
No additional external references are available.